D.E. Shaw & Co
CNMD icon

D.E. Shaw & Co’s CONMED CNMD Stock Holding History

D.E. Shaw & Co’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69M Sell
47,851
-68,150
-59% -$2.77M ﹤0.01% 3039
2025
Q4 		$4.71M Buy
116,001
+49,045
+73% +$2.13M ﹤0.01% 2355
2025
Q3 		$3.15M Sell
66,956
-7,211
-10% -$374K ﹤0.01% 2599
2025
Q2 		$3.86M Buy
74,167
+34,843
+89% +$1.91M ﹤0.01% 2227
2025
Q1 		$2.37M Sell
39,324
-19,713
-33% -$1.27M ﹤0.01% 2487
2024
Q4 		$4.04M Sell
59,037
-11,591
-16% -$808K ﹤0.01% 2145
2024
Q3 		$5.08M Buy
70,628
+45,108
+177% +$3.18M ﹤0.01% 1930
2024
Q2 		$1.77M Buy
25,520
+22,671
+796% +$1.65M ﹤0.01% 2762
2024
Q1 		$228K Buy
+2,849
New +$254K ﹤0.01% 3874
2023
Q4 		– Sell
-61,236
Closed -$6.18M – 4350
2023
Q3 		$6.18M Buy
+61,236
New +$7.04M 0.01% 1642
2023
Q1 		– Sell
-86,608
Closed -$7.68M – 4506
2022
Q4 		$7.68M Buy
86,608
+12,906
+18% +$1.07M 0.01% 1685
2022
Q3 		$5.91M Buy
73,702
+38,051
+107% +$3.59M 0.01% 1899
2022
Q2 		$3.41M Buy
+35,651
New +$4.28M ﹤0.01% 2587
2021
Q2 		– Sell
-7,428
Closed -$970K – 4776
2021
Q1 		$970K Sell
7,428
-8,506
-53% -$1.02M ﹤0.01% 3138
2020
Q4 		$1.78M Sell
15,934
-5,699
-26% -$540K ﹤0.01% 2628
2020
Q3 		$1.7M Sell
21,633
-99,488
-82% -$8.11M ﹤0.01% 2510
2020
Q2 		$8.72M Sell
121,121
-16,096
-12% -$1.12M 0.01% 1275
2020
Q1 		$7.86M Buy
137,217
+123,270
+884% +$11.4M 0.01% 1134
2019
Q4 		$1.56M Buy
+13,947
New +$1.49M ﹤0.01% 2668
2019
Q2 		– Sell
-3,412
Closed -$284K – 3690
2019
Q1 		$284K Sell
3,412
-21,791
-86% -$1.58M ﹤0.01% 3241
2018
Q4 		$1.62M Buy
25,203
+21,778
+636% +$1.49M ﹤0.01% 2326
2018
Q3 		$271K Buy
+3,425
New +$265K ﹤0.01% 3401
2018
Q1 		– Sell
-7,523
Closed -$383K – 3525
2017
Q4 		$383K Buy
+7,523
New +$392K ﹤0.01% 3114
2017
Q3 		– Sell
-6,102
Closed -$311K – 3459
2017
Q2 		$311K Sell
6,102
-4,746
-44% -$235K ﹤0.01% 3014
2017
Q1 		$482K Sell
10,848
-29,185
-73% -$1.26M ﹤0.01% 2752
2016
Q4 		$1.77M Buy
40,033
+33,473
+510% +$1.42M ﹤0.01% 2078
2016
Q3 		$263K Sell
6,560
-69,008
-91% -$2.93M ﹤0.01% 3097
2016
Q2 		$3.61M Buy
75,568
+34,552
+84% +$1.46M 0.01% 1502
2016
Q1 		$1.72M Buy
41,016
+6,636
+19% +$260K ﹤0.01% 1978
2015
Q4 		$1.51M Buy
+34,380
New +$1.49M ﹤0.01% 2344
2015
Q1 		– Sell
-348,867
Closed -$15.7M – 3673
2014
Q4 		$15.7M Buy
348,867
+237,801
+214% +$9.97M 0.02% 837
2014
Q3 		$4.09M Buy
111,066
+32,075
+41% +$1.27M 0.01% 1700
2014
Q2 		$3.49M Buy
78,991
+38,077
+93% +$1.73M ﹤0.01% 1870
2014
Q1 		$1.78M Buy
+40,914
New +$1.82M ﹤0.01% 2509
2013
Q4 		– Sell
-26,683
Closed -$907K – 4478
2013
Q3 		$907K Buy
+26,683
New +$871K ﹤0.01% 3133

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return
CB
Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

D.E. Shaw & Co's CNMD Position: Q1 2026 in Review

D.E. Shaw & Co reduced its CONMED (CNMD) stake by 59% in Q1 2026, selling an estimated $2.77M and leaving 47,851 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #3039.

D.E. Shaw & Co first reported a position in CNMD in Q3 2013 and has held it in 35 quarters since. The position peaked at $15.7M in Q4 2014. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • D.E. Shaw & Co held 47,851 shares of CONMED worth $1.69M as of Q1 2026.
  • D.E. Shaw & Co sold 68,150 CONMED shares in Q1 2026, an estimated $2.77M.
  • CONMED made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #3039 holding.
  • D.E. Shaw & Co first reported a position in CONMED in Q3 2013 and has held it in 35 quarters since.
  • D.E. Shaw & Co's CONMED position peaked at $15.7M in Q4 2014.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.